Neurophysiological differences between patients clinically at high risk for schizophrenia and neurotypical controls--first steps in development of a biomarker.
about
Neurophysiological differences between patients clinically at high risk for schizophrenia and neurotypical controls--first steps in development of a biomarker.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Neurophysiological differences ...... in development of a biomarker.
@ast
Neurophysiological differences ...... in development of a biomarker.
@en
type
label
Neurophysiological differences ...... in development of a biomarker.
@ast
Neurophysiological differences ...... in development of a biomarker.
@en
prefLabel
Neurophysiological differences ...... in development of a biomarker.
@ast
Neurophysiological differences ...... in development of a biomarker.
@en
P2093
P2860
P921
P1433
P1476
Neurophysiological differences ...... in development of a biomarker.
@en
P2093
Alexander Rotenberg
Eugene D'Angelo
Frank H Duffy
Joseph Gonzalez-Heydrich
P2860
P2888
P356
10.1186/S12916-015-0516-Z
P407
P577
2015-11-02T00:00:00Z
P5875
P6179
1043558045